A private equity fund dedicated exclusively to fast-growing private healthcare companies and infrastructure in Africa.
About IFHA (Investment Fund for Health in Africa)
Investment Fund for Health in Africa (IFHA) is an Amsterdam-based private equity fund dedicated exclusively to fast-growing private healthcare companies and infrastructure across the African continent. Check sizes of $5M to $25M and a growth-stage focus place the firm well above the venture range; this is a firm for African healthcare operators with substantial commercial scale, not for early-stage technology founders. The firm is not specifically AI-focused; the lens is healthcare infrastructure, pharmaceuticals, and care delivery operations.
The firm’s natural fit is with African healthcare companies running revenue-scale operations across hospitals and clinics, pharmaceutical manufacturing and distribution, diagnostics chains, and tech-enabled care delivery with proven unit economics. The right CEO profile is a seasoned operator with audited financials, a credible board, and a clear thesis on how growth capital expands a defined market position. Pre-revenue founders, early Series A teams, and pure software AI plays are not the right fit.
Geographically, IFHA’s leverage is real and probably underweighted by founders unfamiliar with the LP base of dedicated Africa health funds. The firm operates across major African markets (Nigeria, Kenya, South Africa, Egypt, Ethiopia, Cote d’Ivoire) with deep operational expertise in African healthcare regulation, supply chain, and payer dynamics. For African operators, the strategic value can be substantial. For non-African operators, the strategic logic is thin.
The right entry path is via an investment banker leading the round, an existing growth-stage co-investor, or a board member with senior African healthcare operating experience. Decks should lead with audited financial history, growth metrics, market position, and a specific use of capital tied to a discrete commercial milestone. Be prepared for multi-month diligence including site visits, regulatory reviews, and management background checks.
Caveats. Growth equity introduces governance complexity, including specific protective provisions, drag-along rights, and exit timing expectations; engage experienced PE-track counsel from the start. African macroeconomic and FX dynamics introduce real risk into PE economics; cross-border holding structures and currency hedging matter. The firm’s investment cadence and current fund vintage are publicly available but may not reflect current dry powder; confirm via direct conversation. For African healthcare operators at growth scale, IFHA is among the most credible specialist PE partners on the continent; for venture-stage technology founders or non-African operators, this is the wrong door.
Founder reviews
Other portfolio companies
Companies in IFHA (Investment Fund for Health in Africa)'s portfolio not currently in our directory.
- CarePay International
- CIEL Healthcare
- Hygeia HMO
- AAR Holdings
- Trivitron Healthcare Africa
- Neuberg Global Laboratories
Team
Pitch / review this investor
Have you raised from IFHA (Investment Fund for Health in Africa)? Founders only — share your honest experience (anonymous OK, moderated before publishing).